$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abstract AI-Helper 아이콘AI-Helper

The expression of vaccine antigens in transgenic plants has the potential to provide a convenient, stable, safe approach for oral vaccination alternative to traditional parenteral vaccines. Over the past two decades, many different vaccine antigens expressed via the plant nuclear genome have elicite...

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • 본 논문에서는 지금까지 발표된 식물-유래 백신용 연구 내용들을 발현-항원별로 분류, 발현-대상 식물체별 분류, 발현율을 높이기 위한 각종 벡터들의 세부 내용, 면역 반응 향상을 위한 어쥬번트들의 효과, 끝으로 일부 연구진들에 의하여 진행된 임상실험들을 조사하여 실용화에 얼마나 가까이 다가와 있는지를 가늠해 볼 수 있는 기회를 제공하고자 하였으며, 나아가 연구개발 현황들을 분석함으로써 앞으로의 전망과 기대치에 대하여 논의해 보고자 하였다.
본문요약 정보가 도움이 되었나요?

질의응답

핵심어 질문 논문에서 추출한 답변
백신의 장점은 무엇인가? 경구용 식물 백신 (plant derived oral vaccine)은 병원체의 항원유전자를 식물에 도입시켜 항원단백질을 합성하는 식물체를 만들어 경구로 투여하고자 하는 기술로서, 1980년대 중반 처음 아이디어가 제시된 후 1990년 Cutiss와 Cardineau 에 의해 처음 시도되어 현재까지 많은 연구가 진행되고 있는 분야이다. 식물을 생산-기반으로 하는 백신은 ① 사람이나 동물의 병원체를 가지지 않는 시스템에서 항원단백질만을 목표로 발현하므로 안정성 확보가 가능하고, ② 식품의 섭식을 통해 처치되므로 백신의 투여에 고통이 따르지 않고 기존 사용 백신에 비하여 거부감이 없으며, ③ 농업체계를 활용한 대량생산으로 백신 생산비용이 저렴하고, ④ 백신의 보관에 cold-chain을 요구하지 않는 등 많은 장점을 가지고 있다. 더욱이, 식물유래 경구백신은 소화관.
경구용 식물 백신은 무엇인가? 경구용 식물 백신 (plant derived oral vaccine)은 병원체의 항원유전자를 식물에 도입시켜 항원단백질을 합성하는 식물체를 만들어 경구로 투여하고자 하는 기술로서, 1980년대 중반 처음 아이디어가 제시된 후 1990년 Cutiss와 Cardineau 에 의해 처음 시도되어 현재까지 많은 연구가 진행되고 있는 분야이다. 식물을 생산-기반으로 하는 백신은 ① 사람이나 동물의 병원체를 가지지 않는 시스템에서 항원단백질만을 목표로 발현하므로 안정성 확보가 가능하고, ② 식품의 섭식을 통해 처치되므로 백신의 투여에 고통이 따르지 않고 기존 사용 백신에 비하여 거부감이 없으며, ③ 농업체계를 활용한 대량생산으로 백신 생산비용이 저렴하고, ④ 백신의 보관에 cold-chain을 요구하지 않는 등 많은 장점을 가지고 있다.
Vaccination의 문제점은 무엇인가? 이러한 장점들과는 달리 아직도 불충분한 발현양의 문제, 면역관용의 우려 제기 및 제어된 공간이 아닌 곳에서의 재배일 경우 대부분의 유전자변형작물들이 가지는 환경 위해성에 대한 검정 등과 같은 해결해야 할 문제들이 극복되지 못하고 있다. 또한, 연구 초기의 식물경구백신이라는 개념은 어떠한 가공 과정도 거치치 않고 항원의 발현 대상 기관 그 자체를 백신으로 취하는 것이었으나 항원의 양을 결정짓기 위한 표준화가 어렵다는 점 등의 이유로 최근에는 순수분리정제를 비롯한 단순 일차 가공을 포함하는 개념으로 좁혀지고 있는 실정이다.
질의응답 정보가 도움이 되었나요?

참고문헌 (114)

  1. Arakawa T, Chong DKX, Merritt JL, Langridge WHR (1997) Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res 6:403-413 

  2. Arakawa T, Chong DKX, Langridge WHR (1998) Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol 16:292-297 

  3. Arlen PA, Singleton M, Adamovicz JJ, Ding Y, Davoodi-Semiromi A, Daniell H (2008) Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect Immun 76:3640-3650 

  4. Arntzen CJ, Coghlan A, Johnson B, Peacock J, Rodemeyer M (2003) GM crops: science, politics and communication. Nat Rev Genet 4:839-843 

  5. Ashraf S, Singh PK, Yadav DK, Shahnawaz M, Mishra S, Sawant SV, Tuli R (2005) High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J Biotechnol 22:1-14 

  6. Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, Liberman Y, Freeman A, Zimran A, Galun E (2009) A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigation. Plos One 4:e4792 

  7. Beyer AJ, Wang K, Umble AN, Wolt JD, Cunnick JE (2007) Lowdose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit. Environ Health Perspect 115:354-360 

  8. Biemelt S, Sonnewald U, Galmbacher P, Willmitzer L, Muller M (2003) Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virology 77:9211-9220 

  9. Carter JE, Langridge WHR (2002) Plant-based vaccines for protection against infectious and autoimmune diseases. Crit Rev Plant Sci 21:93-109 

  10. Chaturvedi CP, Lodhi N, Ansari SA, Tiwari S, Srivastava R, Sawant SV (2007) Mutated TATA-box/TATA binding protein complementation system for regulated transgene expression in tobacco. Plant J 50:917-925 

  11. Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res 11:479-493 

  12. Choi NW, Estes MK, Langridge WH (2006) Synthesis of a ricin toxin B subunit-rotavirus VP7 fusion protein in potato. Mol Biotechnol 32:117-128 

  13. Daniell H, Lee SB, Panchal T, Wiebe PO (2001) Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J Mol Biol 311:1001-1009 

  14. Davoodi-Semiromi A, Schreiber M, Nalapalli S, Verma D, Singh ND, Banks RK, Chakrabarti D, Daniell H (2010) Chloroplastderived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol J 8:223-242 

  15. De Jaeger G, Scheffer S, Jacobs A, Zambre M, Zobell O Goossens A (2002) Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nat Biotechnol 20:1265-1268 

  16. Dong JL, Liang BG, Jin YS, Zhang WJ, Wang T (2005) Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection. Virology 1:153-163 

  17. Fernandez-San MA, Ortigosa SM, Hervas-Stubbs S, Corral-Marti?nez P, Segui?-Simarro JM, Gaetan J, Coursaget P, Veramendi J (2008) Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. J Plant Biotech 6:427-441 

  18. Fischer R, Schumann D, Zimmermann S, Drossard J, Sack M, Schillberg S (1999) Expression and characterization of bispecific single-chain Fv fragments produced in transgenic plants. Eur J Biochem 262:810-816 

  19. Gao Y, Ma Y, Li M, Cheng T, Li SW, Zhang J, Xia NS (2003) Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. World J Gastroenterol 9:996-1002 

  20. Golovkin M, Spitsin S, Andrianov V, Smirnov Y, Xiao Y, Pogrebnyak N, Markley K, Brodzik R, Gleba Y, Isaacs SN, Koprowski H (2007) Smallpox subunit vaccine produced in Planta confers protection in mice. PNAS USA 17:6864-6869 

  21. Gomez N, Carrillo C, Parra F, Salinas J, Borca MV, Escribano M (1998) Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants. Virology 249:352-358 

  22. Gomez N, Wigdorovitz A, Castanon S, Gil F, Ordas R, Borca MV (2000) Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Arch Virol 145:1725-1732 

  23. Guetard D, Greco R, Cervantes Gonzalez M, Celli S, Kostrzak A, Langlade-Demoyen P, Sala F, Wain-Hobson S, Sala M (2008) Immunogenicity and tolerance following HIV-1/HBV plantbased oral vaccine administration. Vaccine 18:4477-4485 

  24. Haq TA, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produce in transgenic plants. Science 5:714-716 

  25. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353-356 

  26. He ZM, Jiang XL, Qi Y, Lou DQ (2008) Assessment of the utility of the tomato fruit-specific E8 promoter for driving vaccine antigen expression. Genetica 133:207-214 

  27. Huang TK, McDonald KA (2009) Bioreactor engineering for recombinant protein production in plant cell suspension culture. Biochemical Engineering J 45:168-184 

  28. Huang Z, Dry I, Webster D, Strugnell R, Wesselingh S (2001) Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. Vaccine 28:2163-2171 

  29. Huber M, Baier W, Bessler WG, Heinevetter L (2002) Modulation of the Th1/Th2 bias by lipopeptide and saponin adjuvants in orally immunized mice. Immunobiology 205:61-73 

  30. Jani D, Meena LS, Rizwan-ul-Haq QM, Singh Y, Sharma AK, Tyagi AK (2002) Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res 11:447-454 

  31. Jiang XL, He ZM, Peng ZQ, Qi Y, Chen Q, Yu SY (2007) Cholera toxin B protein in transgenic tomato fruit induces systemic immune response in mice. Transgenic Res 16:169-175 

  32. Joung YH, Youm JW, Jeon JH, Lee BC, Ryu CJ, Hong HJ, Kim HC, Joung H, Kim HS (2004) Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum. Plant Cell Rep 22:925-930 

  33. Kang TJ, Loc NH, Jang MO, Jang YS, Kim YS, Seo JE, Yang MS (2003) Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. Transgenic Res 12:683-691 

  34. Kapusta J, Modelska A, Pniewski T, Figlerowicz M, Jankowski K, Lisowa O, Plucienniczak A, Koprowski H, Legocki AB (2001) Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Adv Exp Med Biol 495: 299-303 

  35. Karaman S, Cunnick J, Wang K (2006) Analysis of immune response in young and aged mice vaccinated with corn-derived antigen against Escherichia coli heat-labile enterotoxin. Mol Biotechnol 32:31-42 

  36. Kim HS, Euym JW, Kim MS, Lee BC, Mook-Jung I, Jeon JH, Joung H (2003) Expression of human amyloid-beta peptide in transgenic potato. Plant Science 165:1445-1451 

  37. Kim HS, Euym JW, Kim MS, Lee BC, Mook-Jung I, Jeon JH, Joung H (2003) Expression of human amyloid-beta peptide in transgenic potato. Plant Science 165:1445-1451 

  38. Kim TG, Langridge WHR (2003) Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato. Plant Cell Rep 21:884-890 

  39. Kling M, Zeichner JA (2010) The role of the human papillomavirus (HPV) vaccine in developing countries. Int J Dermatol 49:377-379 

  40. Kohl TO, Hitzeroth II, Christensen ND, Rybicki EP (2007) Expression of HPV-11 L1 protein in transgenic Arabodopsis thaliana and Nicotiana tabacum. BMC Biotechnol 12:7-56 

  41. Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. PNAS USA 25:11539-11544 

  42. Kumar GBS, Ganapathi TR, Revathi CJ, Srinvas L, Bapat VA (2005) Expression of hepatitis B surface antigen in transgenic banana plants. Planta 222:484-493 

  43. Kumar GBS, Ganapathi TR, Bapat VA (2007) Production of hepatitis B surface antigen in recombinant plant systems: an update. Biotechnol Prog 23:532-539 

  44. Kwon JY, Cheon SH, Lee HR, Han JY, Kim DI (2009) Production of biopharmaceticlas in transgenic plant cell suspension cultures. J Plant Biotechnol 36:309-319 

  45. Lambrecht BN, Kool M, Willart MA, Hammad H (2009) Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 21:23-29 

  46. Lamphear BJ, Streatfield SJ, Jilka JM, Brooks CA, Barker DK, Turner DD, Delaney DE, Garcia M, Wiggins B, Woodard SL, Hood EE, Tizard IR, Lawhorn B, Howard JA (2002) Delivery of subunit vaccines in maize seed. J Control Release 13:169-180 

  47. Lauterslager TGM, Florack DEA, van der Wal TJ, Molthoff JW, Langeveld JPM, Bosch D, Boersma WJA, Hilgers LAT (2001) Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19:2749-2755 

  48. Lentz EM, Segretin ME, Morgenfeld MM, Wirth SA, Dus Santos MJ, Mozgovoj MV, Wigdorovitz A, Bravo-Almonacid FF (2010) High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants. Planta 231:387-395 

  49. Li JT, Fei L, Mou ZR, Wei J, Tang Y, He HY, Wang L, Wu YZ (2006) Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations. Virology 356:171-178 

  50. Liu HL, Li WS, Lei T, Zheng J, Zhang Z, Yan XF, Wang ZZ, Wang YL, Si LS (2005) Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants. Acta Biochimica et Biophysica Sinica 37:153-158 

  51. Lou XM, Yao QH, Zhang Z, Peng RH, Xiong AS, Wang HK (2007) Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants. Clin Vaccine Immunol 14:464-469 

  52. Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB, Lehner T (1998) Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 4:601-606 

  53. Mason HS, Lam DMK, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. PNAS USA 89:11745-11749 

  54. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. PNAS USA 93:5335-5340 

  55. Mason HS, Haq TA, Clements JD, Arntzen CJ (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16:1336-1343 

  56. Marquet-Blouin E, Bouche FB, Steinmetz A, Muller CP (2003) Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-deirved measles virus hemagglutinin. Plant Mol Biol 51:459-469 

  57. Marusic C, Rizza P, Lattanzi L, Mancini C, Spada M, Belardelli F, Benvenuto E, Capone I (2001) Chimeric plant virus particle as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol 75:8434-8439 

  58. Matoba N, Kajiura H, Cherni I, Doran JD, Bomsel M, Fujiyama K, Mor TS (2009) Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. Plant Biotechnol J 7:129-145 

  59. McCornick AA, Kumagai MH, Hanley K, Turpen TH, Hakim I, Grill LK (1999) Rapid prodiction of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. PNAS USA 96:703-708 

  60. McGarvey PB, Hammond J, Dienelt MM, Hooper DC, Fu ZF, Dietzschold B, Koprowski H, Michaels FH (1995) Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology (NY) 13:1484-1487 

  61. Mishra S, Yadav DK, Tuli R (2006) Ubiquitin fusion enhances cholera toxin B subunit expression in transgenic plants and the plant-expressed protein binds GM1 receptors more efficiently. J Biotechnol 127:95-108 

  62. Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T (2007) Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine 19:1647-1657 

  63. Nemchinov LG, Liang TJ, Rifaat MM, Mazyad HM, Hadidi A, Keith JM (2000) Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Arch Virol 145:2557-2573 

  64. Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M (2007) Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. PNAS USA 104:10986-10991 

  65. Nozoye T, Takaiwa F, Tsuji N, Yamakawa T, Arakawa T, Hayashi Y, Matsumoto Y (2009) Production of Ascaris Suum As14 protein and its fusion protein with cholera toxin B subunit in rice seeds. J Vet Med Sci 71:995-1000 

  66. O'Brien GJ, Bryant CJ, Voogd C, Greenberg HB, Gardner RC, Bellamy AR (2000) Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles. Virology 10:444-453 

  67. Oszvald M, Kang TJ, Tomoskozi S, Jenes B, Kim TG, Cha YS, Tamas L, Yang MS (2008) Expression of cholera toxin B subunit in transgenic rice endosperm. Mol Biotechnol 40:261-268 

  68. Perrin Y, Vaquero C, Gerrard I, Sack M, Drossard J, Stoger E (2000) Transgenic pea seeds as bioreactors for the production of a single-chain Fv fragment (scFV) antibody used in cancer diagnosis and therapy. Mole Breed 6:345-352 

  69. Philip R, Darnowski DW, Maughan PJ, Vodkin LO (2001) Processing and localization of bovine ${\beta}-casein$ expressed in transgenic soybean seeds under control of a soybean lectin expression cassette. Plant Sci 161:323-335 

  70. Pogrebnyak N, Golovkin M, Andrianov V, Spitsin S, Smirnov Y, Egolf R, Koprowski H (2005) Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine. PNAS USA 21:9062-9067 

  71. Portocarrero C, Markley K, Koprowski H, Spitsin S, Golovkin M (2008) Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5. Vaccine 9:5535-5540 

  72. Ramirez YJ, Tasciotti E, Gutierrez-Ortega A, Donayre Torres AJ, Olivera Flores MT, Giacca M, Gomez Lim MA (2007) Fruitspecific expression of the human immunodeficiency virus type 1 tat gene in tomato plants and its immunogenic potential in mice. Clin Vaccine Immunol 14:685-692 

  73. Reed SD, Schulman KA. (2009) Cost Utility of Sequential Adjuvant Trastuzumab for HER2/Neu-Positive Breast Cancer. Value Health 15:637-649 

  74. Richter LJ, Thanavala Y, Arntzen CJ, Mason HS (2000) Procudtion of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18:1167-1171 

  75. Rigano MM, Alvarez ML, Pinkhasov J, Jin Y, Sala F, Arntzen CJ, Walmsley AM (2004) Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. Plant Cell Rep 22:502-508 

  76. Rosales-Mendoza S, Soria-Guerra RE, de Jesus Olivera-Flores MT, Lopez-Revilla R, Arguello-Astorga GR, Jimenez-Bremont JF, Garcia-de la Cruz RF, Loyola-Rodriguez JP, Alpuche-Solis AG (2007) Expression of Escherichia coli heat-labile enterotoxin b subunit (LTB) in carrot (Daucus carota L.). Plant Cell Rep 26:969-976 

  77. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q, Mason HS (2008) An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 28:1846-1854 

  78. Sharma MK, Jani D, Thungapathra M, Gautam JK, Meena LS, Singh Y, Ghosh A, Tyagi AK, Sharma AK (2008) Expression of accessory colonization factor subunit A (ACFA) of Vibrio cholerae and ACFA fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). J Biotechnol 20:22-27 

  79. Shchelkunov SN, Salyaev RK, Pozdnyakov SG, Rekoslavskaya NI, Nesterov AE, Ryzhova TS, Sumtsova VM, Pakova NV, Mishutina UO, Kopytina TV, Hammond RW (2006) Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnol Lett 28:959-967 

  80. Shoji Y, Farrance CE, Bi H, Shamloul M, Green B, Manceva S, Rhee A, Ugulava N, Roy G, Musiychuk K, Chichester JA, Mett V, Yusibov V (2009) Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants. Vaccine 26:3467-3470 

  81. Sojikul P, Buehner N, Mason HS (2003) A plant signal peptidehepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. PNAS USA 4:2209-2214 

  82. Song X, Hu S (2009) Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 6:4883-4890 

  83. Spitsin S, Andrianov V, Pogrebnyak N, Smirnov Y, Borisjuk N, Portocarrero C, Veguilla V, Koprowski H, Golovkin M (2009) Immunological assessment of plant-derived avian flu H5/HA1 variants. Vaccine 25:1289-1292 

  84. Srinvas L, Sunil Kumar GB, Ganapathi TR, Revathi CJ, Bapat VA (2008) Transient and stable expression of hepatitis B surface antigen in tomato (Lycopericon esculentum L.). Plant Biotech Rep 2:1-6 

  85. Stevens LH, Stoopen GM, Elbers IJ, Molthoff JW, Bakker HA, Lommen A, Bosch D, Jordi W (2000) Effect of climate conditions and plant developmental stage on the stability of antibodies expressed in transgenic tobacco. Plant Physiol 124:173-182 

  86. Stoger E, Ma JK, Fischer R, Christou P (2005) Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol 16:167-173 

  87. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in transgenic potato. Nat Med 4:607-609 

  88. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302-305 

  89. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302-305 

  90. Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S (2004) Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22:4385-4389 

  91. Thanavala Y, Yang YF, Lyons P, Mason HS, Arntzen C (1995) Immunogenicity of transgenic plant-derived hepatitis B surface antigen. PNAS USA 11:3358-3361 

  92. Thanavala Y, Mahoney M, Pal S, Scott A, Richter L, Natarajan N (2005) Immunogenicity in humans of an edible vaccine for hepatitis B. PNAS USA 102:3378-3382 

  93. Thanavala Y, Lugade AA (2010) Oral transgenic plant-based vaccine for hepatitis B. Immunol Res 46:4-11 

  94. Tiwari S, Mishra DK, Singh A, Singh PK, Tuli R (2008) Expression of a synthetic cry1EC gene for resistance against Spodoptera litura in transgenic peanut (Arachis hypogaea L.). Plant Cell Rep 27:1017-1025 

  95. Torres E, Vaquero C, Nicholson L, Sack M, Stoger E, Drossard J, Christou P, Fischer R, Perrin Y (1999) Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Res 8:441-449 

  96. Tuboly T, Nagy E (2001) Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene. J Gen Virol 82:183-190 

  97. Varsani A, Williamson AL, Rose RC, Jaffer M, Rybicki EP (2003) Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Archives of Virology 148:1771-1786 

  98. Walmsley AM, Alvarez ML, Jin Y, Kirk DD, Lee SM, Pinkhasov J, Rigano MM, Arntzen CJ, Mason HS (2003) Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Rep 21:1020-1026 

  99. Wampler DE, Lehman ED, Boger J, McAleer WJ, Scolnick EM (1985) Multiple chemical forms of hepatitis B surface antigen produced in yeast. PNAS USA 82:6830-6834 

  100. Wang XG, Zhang GH, Liu CX, Zhang YH, Xiao CZ, Fang RX (2001) Purified cholera toxin B subunit from transgenic tobacco plants possesses authentic antigenicity. Biotechnol Bioeng 20:490-494 

  101. Warzecha H, Mason HS, Lane C, Tryggvesson A, Rybicki E, Williamson AL, Clements JD, Rose RC (2003) Oral immunogenicity of human papillomavirus-like particles expressed in potato. J Virology 77:8702-8711 

  102. Webster DE, Thomas MC, Huang Z, Wesselingh SL (2005) The development of a plant-based vaccine for measles. Vaccine 7:1859-1865 

  103. Webster DE, Smith SD, Pickering RJ, Strugnell RA, Dry IB, Wesseling SL (2006) Measles virus hemagglutinin protein expressed in transgenic lettuce induces neutralising antibodies in mice following mucosal vaccination. Vaccine 24:3538-3544 

  104. Wigdorovitz A, Carrillo C, Dus Santos MJ, Trono K, Peralta A, Gomez MC (1999) Induction of a protective antibody response to foot and mouth disease in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255:347-353 

  105. Wu HY, Russell MW (1998) Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. Vaccine 16:286-292 

  106. Wu YZ, Li JT, Mou ZR, Fei L, Ni B, Geng M, Jia ZC, Zhou W, Zou LY, Tang Y (2003) Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. Virology 1:337-342 

  107. Xiao C, Rajput ZI, Hu S (2007) Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A. Vaccine 15:4795-4800 

  108. Yang ZQ, Liu QQ, Pan ZM, Yu HX, Jiao XA (2007) Expression of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice. Vaccine 8:591-598 

  109. Youm JW, Kim H, Han JHL, Jang CH, Ha HJ, Mook-Jung I, Jeon JH, Choi CY, Kim YH, Kim HS, Joung H (2005) Transgenic potato expressing $A{\beta}$ reduce $A{\beta}$ burden in Alzheimer’s disease mouse model. FEBS Lett 579:6737-6744 

  110. Youm JW, Won YS, Jeon JH, Ryu CJ, Choi YK, Kim HC, Kim BD, Joung H, Kim HS (2007) Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice. Vaccine 5:577-584 

  111. Youm JW, Jeon JH, Kim H, Kim YH, Ko K, Joung H, Kim HS (2008) Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease. Biotechnol Lett 30:1839-1845 

  112. Youm JW, Jeon JH, Kim H, Min SR, Kim MS, Joung H, Jeong WJ, Kim HS (2010) High-level expression of a human beta-site APP cleaving enzyme in transgenic tobacco chloroplasts and its immunogenicity in mice. Transgenic Res 15 

  113. Yu J, Langridge W (2003) Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Res 12:163-169 

  114. Zhang X, Buehner NA, Hutson AM, Estes MK, Mason HS (2006) Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J 4:419-432 

저자의 다른 논문 :

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로